Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which...
11 insider purchases on record · latest filing 2023-08-24.
Insiders have also filed 67 sale transactions at SEER.